Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Spierontspanning perfect te meten met magnetische hersenstimulatie
apr 2024 | Neuro-musculair